These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34814176)

  • 21. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis.
    Fingerhut R; Rueegg CS; Imahorn O; Pedersen ESL; Kuehni CE; Gallati S; Regamey N; Barben J
    Arch Dis Child Fetal Neonatal Ed; 2023 Mar; 108(2):176-181. PubMed ID: 36351789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.
    Massie RJ; Wilcken B; Van Asperen P; Dorney S; Gruca M; Wiley V; Gaskin K
    J Pediatr; 2000 Aug; 137(2):214-20. PubMed ID: 10931414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome.
    Gunnett MA; Baker E; Mims C; Self ST; Gutierrez HH; Guimbellot JS
    Front Pediatr; 2023; 11():1127659. PubMed ID: 36969284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM; Koscik RE
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
    Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF
    J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.
    Munck A; Delmas D; Audrézet MP; Lemonnier L; Cheillan D; Roussey M
    J Med Screen; 2018 Mar; 25(1):6-12. PubMed ID: 28454512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial assessments.
    Manzoor J; Hughes DA
    Paediatr Respir Rev; 2023 Sep; 47():19-22. PubMed ID: 37365112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of repeat sweat testing in cystic fibrosis newborn screen positive infants.
    Bauer SE; Wesson M; Oles SK; Ren CL
    Pediatr Pulmonol; 2021 Jun; 56(6):1521-1526. PubMed ID: 33512069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnosis of cystic fibrosis.
    De Boeck K; Vermeulen F; Dupont L
    Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed diagnosis of cystic fibrosis in children with a rare genotype (delta F508/R117H).
    Fitzgerald D; Van Asperen P; Henry R; Waters D; Freelander M; Wilson M; Wilcken B; Gaskin K
    J Paediatr Child Health; 1995 Jun; 31(3):168-71. PubMed ID: 7669372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of infants whose diagnosis is inconclusive at neonatal screening for cystic fibrosis].
    Sermet-Gaudelus I; Brouard J; Audrézet MP; Couderc Kohen L; Weiss L; Wizla N; Vrielynck S; LLerena K; Le Bourgeois M; Deneuville E; Remus N; Nguyen-Khoa T; Raynal C; Roussey M; Girodon E
    Arch Pediatr; 2017 Apr; 24(4):401-414. PubMed ID: 28258861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
    Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
    Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Barben J; Castellani C; Munck A; Davies JC; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Mayell SJ; McColley S; Ooi CY; Proesmans M; Ren CL; Salinas D; Sands D; Sermet-Gaudelus I; Sommerburg O; Southern KW;
    J Cyst Fibros; 2021 Sep; 20(5):810-819. PubMed ID: 33257262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy.
    Terlizzi V; Mergni G; Buzzetti R; Centrone C; Zavataro L; Braggion C
    J Cyst Fibros; 2019 Jul; 18(4):484-490. PubMed ID: 31005549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image-based β-adrenergic sweat rate assay captures minimal cystic fibrosis transmembrane conductance regulator function.
    Salinas DB; Peng YH; Horwich B; Wee CP; Frisbee E; Maarek JM
    Pediatr Res; 2020 Jan; 87(1):137-145. PubMed ID: 31344706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.